The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
Zhang, S., Ermann, J., Succi, M. D., Zhou, A., Hamilton, M. J., Cao, B., Korzenik, J. R., Glickman, J. N., Vemula, P. K., Glimcher, L. H., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5657 · Cited by 467
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Deciphering the catalytic mechanism of superoxide dismutase activity of carbon dot nanozyme
Gao, W., He, J., Chen, L., Meng, X., Ma, Y., Cheng, L., Tu, K., Gao, X., Liu, C., Zhang, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35828-2 · Cited by 622
Superoxide dismutase nanozymes: an emerging star for anti-oxidation
Zhao, H., Zhang, R., Yan, X., & Fan, K. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00720c · Cited by 529
Reactive Oxygen Species‐Regulating Strategies Based on Nanomaterials for Disease Treatment
Zhang, C., Wang, X., Du, J., Gu, Z., & Zhao, Y. (2021) · Advanced Science · doi:10.1002/advs.202002797 · Cited by 401
Advances in Oral Drug Delivery Systems: Challenges and Opportunities
Lou, J., Duan, H., Qin, Q., Teng, Z., Gan, F., Zhou, X., & Zhou, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020484 · Cited by 397
Metadata
- Authors
- Zhang, Q., Tao, H., Lin, Y., Hu, Y., An, H., Zhang, D., Feng, S., Hu, H., Wang, R., Li, X., & Zhang, J.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 105
- Pages
- 206-221
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2511102702
- Cited by
- 234
- References
- 1
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.